SCHEMBL4728213

SCHEMBL4728213

NS(=O)(=O)C1CCCC[N]1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
APLNR P35414 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2333004 0.79
SCHEMBL1521621 0.76
SCHEMBL7286316 0.69 KMT2A (0.30)
SCHEMBL1903501 0.68
SCHEMBL4346471 0.66 NOS1 (0.31)
SCHEMBL2646556 0.64
SCHEMBL335650 0.64 APLNR (0.41) APLNR
SCHEMBL244348 0.62
SCHEMBL1649129 0.60 CA1 (0.52) CA1CA2APLNR
SCHEMBL14462832 0.60 CA1 (0.52) CA1CA2APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107690434-B Fused tricyclic imidazopyrazine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2021-07-30 CN disclosed
CN-105829307-B Tetrahydroimidazopyridine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2020-07-24 CN disclosed
WO-2008020904-A2 METHOD FOR REDUCING THE RISK OF OR PREVENTING INFECTION DUE TO SURGICAL OR INVASIVE MEDICAL PROCEDURES RIB-X PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed